Dienogest

In: Reactions Weekly · 2023 · vol. 1948(1) , pp. 166 · doi:10.1007/s40278-023-35723-8 · W4360958460
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-07+body, 2026-07-24 ⓘ

This case report details the concurrent occurrence of endometrial and ovarian cancer in a patient undergoing hormonal therapy with dienogest.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Full text 508 characters · extracted from oa-doi-fallback · click to expand
Reference Tetsu O, et al. Concurrence of Endometrial Cancer and Ovarian Cancer during Hormonal Therapy of Dienogest: A Case Report. Journal of Obstetrics and Gynaecology Research 49: 415, No. 1, Jan 2023. Available from: URL: http://doi.org/10.1111/jog.15530 [abstract] Rights and permissions About this article Cite this article Dienogest. Reactions Weekly 1948, 166 (2023). https://doi.org/10.1007/s40278-023-35723-8 Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s40278-023-35723-8

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (1)

Source provenance

openalex
last seen: 2026-05-11T05:21:01.430805+00:00
License: CC0 · commercial use OK